Late onset hexosaminidase A deficiency in a young adult

European Journal of Neurology

Volumn 15, Issue 7, 2008, Pages

  Peters, A S ^a   Markovic, K ^a   Schramm, A ^a   Schwab, S ^a   Heuss, D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ALS; Hexosaminidase A deficiency

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE A;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANAMNESIS; AUTOSOMAL RECESSIVE INHERITANCE; BABINSKI REFLEX; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAM; ENZYME ACTIVITY; GM2 GANGLIOSIDOSIS; HUMAN; LETTER; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TAY SACHS DISEASE;

ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; HUMANS; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; TAY-SACHS DISEASE;

EID: 44949222399     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02170.x     Document Type: Letter

References (5)

1. Mitsumoto H, Sliman RJ, Schafer IA, et al. Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Annals of Neurology 1985 17 : 378 385.
2. Mahuran DJ. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochimica et Biophysica Acta 1999 1455 : 105 138.
3. Maegawa GH, Tropak M, Buttner J, et al. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis. Journal of Biological Chemistry 2007 282 : 9150 9161. Epub 2007 Jan 21.
4. Shapiro BE, Hatters-Friedman S, Fernandes-Filho JA, Anthony K, Natowicz MR. Late-onset Tay-Sachs disease: adverse effects of medications and implications for treatment. Neurology 2006 67 : 875 877.
5. Gudesblatt M, Ludman MD, Cohen JA, et al. Hexosaminidase a activity and amyotrophic lateral sclerosis. Muscle and Nerve 1988 11 : 3.